-
Something wrong with this record ?
Preoperative radiotherapy and concomitant capecitabine treatment induce thymidylate synthase and thymidine phosphorylase mRNAs in rectal carcinoma
I Kocakova, M Svoboda, K Kubosova, V Chrenko, E Roubalova, E Krejci, R Sefr, P Slampa, T Frgala, J Zaloudik
Language English Country Slovakia
- MeSH
- Deoxycytidine administration & dosage therapeutic use MeSH
- Adult MeSH
- Fluorouracil analogs & derivatives therapeutic use MeSH
- Genetic Markers MeSH
- Carcinoembryonic Antigen blood MeSH
- Combined Modality Therapy MeSH
- Middle Aged MeSH
- Humans MeSH
- RNA, Messenger genetics MeSH
- Rectal Neoplasms MeSH
- Polymerase Chain Reaction MeSH
- Antimetabolites, Antineoplastic therapeutic use MeSH
- Pyrimidines metabolism MeSH
- Aged MeSH
- Neoplasm Staging MeSH
- Thymidine Phosphorylase genetics MeSH
- Thymidylate Synthase genetics MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Aged MeSH
This work is intended to study the effect of preoperative capecitabine and radiotherapy treatment on the levels of thymidylate synthase (TS), thymidine phosphorylase (TP) and dihydropyrimidine dehydrogenase (DPD) mRNAs in rectal carcinoma. 55 patients with locally advanced rectal carcinoma (cT3-4, N0, M0 or cT2-4,N+, M0) were treated with capecitabine 825 mg/m2 twice a day and pelvic radiotherapy 1,8 Gy daily up to cumulative dose of 45 Gy, boosting up to 50,4 Gy. Patients underwent surgery 6th week after the completion of chemoradiotherapy. Biopsies of rectal carcinoma were taken before starting therapy and 14 days after its cesation. Biopsies were examined for TS, DPD and TP mRNA levels. CEA in serum was examined to monitor relapses. Both TP and TS mRNA increase two weeks after starting therapy (p<0,001). TP mRNA median levels were elevated 2,3x after starting therapy. Moreover responders exhibit 1,5x higher induction than non-responders both before and after starting therapy, but difference is significant before therapy only (p=0,017). Non-responders have most frequent TS induction. Complete remission was observed in 17% and substantial responses with microscopic residuum only in additional 19% of cases were achieved. The pathologic downstaging rate was 76%. Our data show that TS and TP mRNA are induced by preoperative chemoradiotherapy in both responders and nonresponders. TP induction is in accordance with the expected role of TP in the activation of capecitabine and the known promoting role of TP in tissue fibrosis frequently associated with tumor regression.
- 000
- 03831naa 2200577 a 4500
- 001
- bmc10015032
- 003
- CZ-PrNML
- 005
- 20111210175734.0
- 008
- 100623s2007 xo e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xo
- 100 1_
- $a Kocáková, Ilona, $d 1959- $7 xx0018907
- 245 10
- $a Preoperative radiotherapy and concomitant capecitabine treatment induce thymidylate synthase and thymidine phosphorylase mRNAs in rectal carcinoma / $c I Kocakova, M Svoboda, K Kubosova, V Chrenko, E Roubalova, E Krejci, R Sefr, P Slampa, T Frgala, J Zaloudik
- 314 __
- $a Clinic of Comprehensive Cancer Care, Laboratory of Predictive Oncology, Dept. of Clin. & Exp. Pathology, Masaryk Memorial Cancer Institute, Brno, Czech Republic
- 520 9_
- $a This work is intended to study the effect of preoperative capecitabine and radiotherapy treatment on the levels of thymidylate synthase (TS), thymidine phosphorylase (TP) and dihydropyrimidine dehydrogenase (DPD) mRNAs in rectal carcinoma. 55 patients with locally advanced rectal carcinoma (cT3-4, N0, M0 or cT2-4,N+, M0) were treated with capecitabine 825 mg/m2 twice a day and pelvic radiotherapy 1,8 Gy daily up to cumulative dose of 45 Gy, boosting up to 50,4 Gy. Patients underwent surgery 6th week after the completion of chemoradiotherapy. Biopsies of rectal carcinoma were taken before starting therapy and 14 days after its cesation. Biopsies were examined for TS, DPD and TP mRNA levels. CEA in serum was examined to monitor relapses. Both TP and TS mRNA increase two weeks after starting therapy (p<0,001). TP mRNA median levels were elevated 2,3x after starting therapy. Moreover responders exhibit 1,5x higher induction than non-responders both before and after starting therapy, but difference is significant before therapy only (p=0,017). Non-responders have most frequent TS induction. Complete remission was observed in 17% and substantial responses with microscopic residuum only in additional 19% of cases were achieved. The pathologic downstaging rate was 76%. Our data show that TS and TP mRNA are induced by preoperative chemoradiotherapy in both responders and nonresponders. TP induction is in accordance with the expected role of TP in the activation of capecitabine and the known promoting role of TP in tissue fibrosis frequently associated with tumor regression.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a protinádorové antimetabolity $x terapeutické užití $7 D000964
- 650 _2
- $a karcinoembryonální antigen $x krev $7 D002272
- 650 _2
- $a kombinovaná terapie $7 D003131
- 650 _2
- $a deoxycytidin $x aplikace a dávkování $x terapeutické užití $7 D003841
- 650 _2
- $a fluoruracil $x analogy a deriváty $x terapeutické užití $7 D005472
- 650 _2
- $a genetické markery $7 D005819
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a staging nádorů $7 D009367
- 650 _2
- $a polymerázová řetězová reakce $7 D016133
- 650 _2
- $a pyrimidiny $x metabolismus $7 D011743
- 650 _2
- $a messenger RNA $x genetika $7 D012333
- 650 _2
- $a nádory rekta $7 D012004
- 650 _2
- $a thymidinfosforylasa $x genetika $7 D013939
- 650 _2
- $a thymidylátsynthasa $x genetika $7 D013940
- 700 1_
- $a Svoboda, Marek, $d 1975- $7 xx0098478
- 700 1_
- $a Kubošová, Klára. $7 _AN050584
- 700 1_
- $a Chrenko, Vojtěch, $d 1950- $7 xx0061125
- 700 1_
- $a Roubalova, E
- 700 1_
- $a Krejčí, Eva $7 xx0061138
- 700 1_
- $a Šefr, Roman, $7 xx0060111 $d 1963-
- 700 1_
- $a Šlampa, Pavel, $d 1960- $7 mzk2004257405
- 700 1_
- $a Frgala, Tomáš. $7 _AN026427
- 700 1_
- $a Žaloudík, Jan, $d 1954- $7 nlk20000083399
- 773 0_
- $t Neoplasma $w MED00003470 $g Roč. 54, č. 5 (2007), s. 447-453 $x 0028-2685
- 910 __
- $a ABA008 $b A 1194 $y 8
- 990 __
- $a 20100629151658 $b ABA008
- 991 __
- $a 20100629151658 $b ABA008
- 999 __
- $a ok $b bmc $g 750900 $s 614578
- BAS __
- $a 3
- BMC __
- $a 2007 $b 54 $c 5 $d 447-453 $i 0028-2685 $m Neoplasma $n Neoplasma $x MED00003470
- LZP __
- $a 2010-B1/mkme